USE OF LONG CHAIN FATTY ACIDS ESTERS FOR THE TREATMENT OF AUTOIMMUNE DISEASES.

摘要

Use of an ester of a saturated or cis-unsaturated C 18 fatty acid with a C 1 -C 24 alkanol, with a polyol having at least four hydroxy groups or an anhydrous derivative thereof, or with a monosaccharide, or a combination of said esters, for the preparation of a pharmaceutical composition for the treatment of autoimmune organospecific diseases.